United Kingdom
Precision Cardiovascular is at the forefront of heart failure management, leveraging AI-powered wearables to monitor heart health continuously and intervene early. Their revolutionary approach provides real-time monitoring for high-risk cardiovascular patients. Founded in 2021, this UK-based startup positions itself uniquely within the Health Care and Health and Wellness industries.
Their mission centers on transforming cardiovascular care by equipping both patients and clinicians with cutting-edge tools for proactive heart failure management. Currently in pre-clinical development, their flagship solution promises to enhance the quality of life through timely insights for interventions.
Precision Cardiovascular secured a seed investment from 500 Global on September 1, 2025, underscoring investor confidence in its potential to revolutionize heart health. This early backing highlights the company's innovative capability and growth potential in a burgeoning market.
